JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia.

Abstract

JAK2 V617F and MPL W515L/K mutations have been reported in approximately 50% and 5% of the patients with essential thrombocythemia (ET), respectively. We investigated the frequency of MPL W515L/K mutations in a series of consecutive patients with ET and post-essential thrombocythemia myelofibrosis (post-ET MF). The study subjects were 63 patients diagnosed… (More)
DOI: 10.3343/kjlm.2010.30.5.474

Topics

1 Figure or Table

Cite this paper

@article{Kim2010JAK2VA, title={JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia.}, author={Hee-Jin Kim and Ja-Hyun Jang and Eun-Hyung Yoo and Chang Seok Ki and Jong-Won Kim and Sun Ran Kim}, journal={The Korean journal of laboratory medicine}, year={2010}, volume={30 5}, pages={474-6} }